Description:
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual and agonist that is being developed for the treatment of type 2 diabetes.
GLP-1 agonists
were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called
Semaglutide & Tirzepatide
. Semaglutide is also known Ozempic or Wegovy. Tirzepatide is known as
Mounjaro
,which
is dosed at 5-15mg per week,but we only can supply Tirzepatide powder.